Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic Dystrophies

Journal of Neurodegenerative Diseases
A RomigiR Massa

Abstract

Myotonic dystrophy is the most common type of muscular dystrophy in adults and is characterized by progressive myopathy, myotonia, and multiorgan involvement. Two genetically distinct entities have been identified, myotonic dystrophy type 1 (DM1 or Steinert's Disease) and myotonic dystrophy type 2 (DM2). Myotonic dystrophies are strongly associated with sleep dysfunction. Sleep disturbances in DM1 are common and include sleep-disordered breathing (SDB), periodic limb movements (PLMS), central hypersomnia, and REM sleep dysregulation (high REM density and narcoleptic-like phenotype). Interestingly, drowsiness in DM1 seems to be due to a central dysfunction of sleep-wake regulation more than SDB. To date, little is known regarding the occurrence of sleep disorders in DM2. SDB (obstructive and central apnoea), REM sleep without atonia, and restless legs syndrome have been described. Further polysomnographic, controlled studies are strongly needed, particularly in DM2, in order to clarify the role of sleep disorders in the myotonic dystrophies.

References

Dec 1, 1991·Acta Neurologica Scandinavica·R ManniA Tartara
Nov 1, 1990·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·R BroughtonW Dunham
Dec 1, 1987·Journal of Neurology·F CirignottaE Lugaresi
Apr 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·J D Park, R A Radtke
Feb 1, 1995·Journal of the Neurological Sciences·S OnoK Nagao
May 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·F G van der MechéH F Busch
Jan 1, 1993·Journal of the Neurological Sciences·J J van HiltenA R Wintzen
Oct 23, 1997·Current Opinion in Neurology·D Hilton-Jones
Jun 1, 1997·Journal of Sleep Research·L S BennettR J Davies
Mar 31, 1998·Archives of Neurology·T Ashizawa
May 12, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·J S RubinszteinA J Holland
Jun 15, 1999·Journal of Neurology·M F PhillipsP S Harper
Jun 29, 1999·Journal of the Neurological Sciences·F GiubileiC Fieschi
Jan 18, 2003·Sleep Medicine Reviews·Raymond CluydtsPaul Theys
Jun 12, 2003·Neuromuscular Disorders : NMD·K TalbotD Hilton-Jones
May 1, 1961·Journal of Neurology, Neurosurgery, and Psychiatry·J C PHEMISTER, J M SMALL
Nov 26, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·Y DauvilliersC L Bassetti
Mar 5, 2004·Journal of Sleep Research·Luc LabergeJean Mathieu
Dec 15, 2004·Archives of Neurology·Annette GeorgeClaudia Sommer
Mar 29, 2005·Neuromuscular Disorders : NMD·S WinbladS Hansen
Sep 20, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·L LabergeJ Mathieu
Sep 20, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·J S KalkmanG Bleijenberg
Aug 29, 2006·Neuromuscular Disorders : NMD·Maria-Antonia Quera SalvaDelphine Heron
Apr 11, 2007·Neurology·M H PennestriP A Lanfranchi
May 9, 2007·Muscle & Nerve·Giovanni Meola, Valeria Sansone
Aug 29, 2007·Journal of Rehabilitation Medicine·Cynthia GagnonLuc Noreau
Jan 16, 2008·Neurology·E CiafaloniC A Thornton
Feb 6, 2008·Sleep·Timothy I MorgenthalerUNKNOWN Standards of Practice Committee of the American Academy of Sleep Medicine
Mar 14, 2008·Neuromuscular Disorders : NMD·Alfonso Di CostanzoGioacchino Tedeschi
Feb 13, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·L LabergeJ Mathieu
May 1, 2009·Neuromuscular Disorders : NMD·Luc LabergeJean Mathieu
Jun 2, 2009·Sleep & Breathing = Schlaf & Atmung·Esen KiyanFeza Deymeer

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.